Akebia Therapeutics | AKBA - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Amgen USD 51.89B 1.88B 2026-03
Ardelyx USD 203.52M 683K 2026-03
Astellas Pharma JPY 320B 0 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Celltrion KRW 412.27B 348.97B 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 37.53B 1.91B 2026-03
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 603M 7M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 33.16M 3.52M 2026-03
Prothena USD 0 0 2024-12
PTC Therapeutics USD 286.94M 1.74B 2026-03
Qiagen NV USD 1.65B 15.23M 2025-12
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Sartorius EUR 3.34B 152.8M 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 17K 26K 2026-03
Tilray USD 268.59M 3.82M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03